Donday, M G
15  results:
Search for persons X
?
1

P550 Management of immunomodulators and biologic agents in ..:

Chaparro, M ; Donday, M G ; Rubio, S...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i496-i498 , 2022
 
?
2

P186 Association between anti-TNF serum levels and mucosal ..:

Chaparro, M. ; Barreiro-de Acosta, M. ; Echarri, A....
Journal of Crohn's and Colitis.  11 (2017)  suppl_1 - p. S171-S171 , 2017
 
?
3

Anti-tumour necrosis factor discontinuation in inflammatory..:

Chaparro, María ; Donday, María G. ; Barreiro-de Acosta, Manuel...
Therapeutic Advances in Gastroenterology.  12 (2019)  - p. 175628481987420 , 2019
 
?
5

DOP80 Prevalence and factors associated with Inflammatory B..:

Chaparro, M ; García Donday, M ; Núñez Ortiz, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i222-i225 , 2024
 
?
6

P744 Safety of live vaccines in children exposed to biologi..:

Chaparro, M ; García Donday, M ; Rubio, S...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i874-i876 , 2023
 
?
7

DOP52 Safety of Inflammatory Bowel Disease drugs during pre..:

Chaparro, M ; García Donday, M ; Calviño Suarez, C...
Journal of Crohn's and Colitis.  15 (2021)  Supplement_1 - p. S086-S088 , 2021
 
?
10

Prospective, study comparing the accuracy of two different ..:

McNicholl, Adrian G. ; Garre, Ana ; Llorca, Laura...
Gastroenterología y Hepatología (English Edition).  43 (2020)  3 - p. 117-125 , 2020
 
?
12

Efficacy and safety of rifaximin associated with standard t..:

Ramas, Mercedes ; Donday, Maria G. ; McNicholl, Adrian G..
Gastroenterología y Hepatología (English Edition).  40 (2017)  10 - p. 658-662 , 2017
 
?
15

OP37 Is the withdrawal of anti-tumour necrosis factor in in..:

Chaparro, M ; García Donday, M ; Riestra, S...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i50-i54 , 2023
 
1-15